Rank #1: 059 - The five oncology drugs every pharmacist should know about
In this episode, we discuss with Dr. Megan Hartranft the five oncology drugs that every pharmacist should know about, which is a great review for P4 students who are currently preparing for the NAPLEX. We cover cyclophosphamide, cisplatin, methotrexate, doxorubicin, and vincristine.
Apr 11 2017
Rank #2: 071 - Holy Hypertension Guidelines - Holiday Edition!
In this episode, we review the important changes in 2017 ACC/AHA guidelines for hypertension management in adults.
Dec 19 2017
Rank #3: 113 - The Top 10 Clinical Pearls for Total Parenteral Nutrition (TPN)
In this episode, we review ten clinical pearls about total parenteral nutrition (TPN) that all pharmacists should know.
May 19 2020
Rank #4: 043 - Review of Diabetic Ketoacidosis (DKA)
In this episode, we review the clinical presentation and treatment of diabetic ketoacidosis (DKA).
May 10 2016
Rank #5: 106 - It’s Finally Here! The 2019 IDSA CAP Guidelines
In this episode, we discuss the important updates in the 2019 IDSA Community Acquired Pneumonia (CAP) guidelines with Dr. Christie Bertram, PharmD, an Infectious Diseases Clinical Pharmacist and Assistant Professor at Rosalind Franklin University’s College of Pharmacy.
Dec 24 2019
Rank #6: 076 - The New Move: Treating Tardive Dyskinesia
In this episode, we discuss two new agents (valbenazine and deutetrabenazine) -- the first of their kind to receive FDA approval to manage tardive dyskinesia most commonly associated with antipsychotic use.
Apr 03 2018
Rank #7: 018 - HIV
In this episode, we review HIV therapy with Dr. Cottreau with a particular focus on Truvada, Atripla, Complera, Stribild, and Triumeq.
Dec 02 2014
Rank #8: 052 - Drug Mixology and Dangerous Consequences, Part I
In this episode, we discuss some of the most important drug interactions, including serotonin syndrome, St. John's wort, statins and CYP inhibitors, and antihypertensive medications with NSAIDs.
Nov 15 2016
Rank #9: 072 - Drop It Like It’s Hot: Prazosin and the 2017 VA/DoD PTSD Guidelines
In this episode, we will review the surprising results of the VA/DoD's 2017 Clinical Practice Guidelines on Management of PTSD, particularly as it relates to the use of one particular agent, prazosin.
Jan 09 2018
Rank #10: 057 - Kicking acid, taking names ... the story of PPI use and abuse
In this episode, we discuss the overuse of proton pump inhibitor (PPI) therapy and several concerns regarding chronic use of this medication class, including hypomagnesemia, fracture risk, low seurm B12 levels, anemias, and increased risk of certain infections.
Feb 28 2017
Rank #11: 067 - Diabetes: does it cost a “heart” and a leg?
In this episode, we discuss new evidence for cardiovascular outcomes in diabetics based on the LEADER trial (liraglutide) and CANVAS trials (canagliflozin). We also discuss the new FDA warning for canagliflozin regarding amputation risk.
Sep 26 2017
Rank #12: 048 - Self-Care of Nasal Congestion and Allergies
In this episode, we discuss the self-care of nasal congestion and allergies, including systemic/topical decongestants, nasal corticosteroids, antihistamines, cromolyn, and alternative medicine therapies.
Aug 23 2016
Rank #13: 068 - Hooked on a feeling: how to discuss benzodiazepine tapers with your patients
In this episode, we will discuss the current state of benzodiazepine use, expected trends in prescribing, and risks associated with use. Lastly, we will discuss techniques for ensuring that a benzodiazepine taper is performed in a safe manner with lowest risk of harm.
Oct 17 2017
Rank #14: 034 - New Injectable Insulins
In this podcast, we discuss three new injectable insulin formations: Toujeo (insulin glargine U-300), Humalog U-200 (insulin lispro), and Tresiba (insulin degludec).
Nov 03 2015
Rank #15: 080 - HIT Me With Your Best Shot: A Brief Review of Heparin-Induced Thrombocytopenia (HIT)
In this episode, we will review the diagnosis and treatment of heparin-induced thrombocytopenia (HIT).
Jun 26 2018
Rank #16: 032 - ARNIs and Entresto
In this episode, we discuss the new drug class, ARNI, recently approved for heart failure with a focus on sacubatril/valsartan (Entresto) and the PARADIGM-HF trial.
Sep 22 2015
Rank #17: 086 - Everything You Need to Know About Insulins - In One Shot!
In this episode, we discuss a broad overview of insulin topics ranging from the various types of insulins, dosage forms, brand/generic names, pharmacokinetic nuances, injection technique, and a wide variety of clinical pearls.
Oct 30 2018
Rank #18: 095 - The Ultimate Guide to NSAIDs: An In-Depth Drug Class Review
In this episode, we will review the pharmacology, efficacy, and safety of the most common NSAIDs on the market.
May 07 2019
Rank #19: 016 - New diabetes medications
In this episode, we discuss newly approved agents for diabetes mellitus: Afrezza (inhaled human insulin), SGLT2 inhibitors (Invokana, Farxiga, Jardiance), and long-acting GLP-1 agonists (Bydureon, Tanzeum).
Nov 04 2014
Rank #20: 094 - The Sweet Sweet Taste of Annually Updated Guidelines: 2019 Standards of Diabetes Care
In this episode, we discuss the changes made in the American Diabetes Association’s 2019 Standards of Diabetes Care guideline as well as updates in therapy recommendations per ADA and ESDA consensus statement published in Fall 2018.
Apr 16 2019